LitCovid-sentences  

PMC:7212965 / 5490-8748 JSONTXT 10 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T29 0-17 Sentence denotes Scope and Purpose
T30 18-129 Sentence denotes We seek to summarize international data on the Gl and liver manifestations of COVID-19 infection and treatment.
T31 130-268 Sentence denotes Additionally, this document provides evidence-based clinical guidance on clinical questions that gastroenterologists may be consulted for.
T32 269-584 Sentence denotes This rapid review document was commissioned and approved by the AGA Institute Clinical Guidelines Committee, AGA Institute Clinical Practice Updates Committee, and the AGA Governing Board to provide timely, methodologically rigorous guidance on a topic of high clinical importance to the AGA members and the public.
T33 585-664 Sentence denotes Table 1 provides a summary of the recommendations and best practice statements.
T34 665-709 Sentence denotes Table 1 Summary of Best Practice Statements:
T35 710-761 Sentence denotes Consultative Management of Coronavirus Disease 2019
T36 762-775 Sentence denotes Statement no.
T37 776-785 Sentence denotes Statement
T38 786-1168 Sentence denotes 1 In outpatients with new-onset diarrhea, ascertain information about high-risk contact exposure; obtain a detailed history of symptoms associated with COVID-19, including fever, cough, shortness of breath, chills, muscle pain, headache, sore throat, or new loss of taste or smell; and obtain a thorough history for other Gl symptoms, including nausea, vomiting, and abdominal pain.
T39 1169-1378 Sentence denotes 2 In outpatients with new-onset Gl symptoms (eg, nausea, vomiting, abdominal pain, and diarrhea), monitor for symptoms associated with COVID-19, as GI symptoms may precede COVID-related symptoms by a few days.
T40 1379-1456 Sentence denotes In a high COVID-19 prevalence setting, COVID-19 testing should be considered.
T41 1457-1670 Sentence denotes 3 In hospitalized patients with suspected or known COVID-19, obtain a thorough history of GI symptoms (ie, nausea, vomiting, abdominal pain, and diarrhea), including onset, characteristics, duration, and severity.
T42 1671-1814 Sentence denotes 4 There is presently inadequate evidence to support stool testing for diagnosis or monitoring of COVID-19 as part of routine clinical practice.
T43 1815-1955 Sentence denotes 5 In patients (outpatients or inpatients) with elevated LFTs in context of suspected or known COVID-19, evaluate for alternative etiologies.
T44 1956-2181 Sentence denotes 6 In hospitalized patients with suspected or known COVID-19, obtain baseline LFTs at the time of admission and consider LFT monitoring throughout the hospitalization, particularly in the context of drug treatment for COVID-19
T45 2182-2311 Sentence denotes 7 In hospitalized patients undergoing drug treatment for COVID-19, evaluate for treatment-related Gl and hepatic adverse effects.
T46 2313-2366 Sentence denotes Panel Composition and Conflict of Interest Management
T47 2367-2491 Sentence denotes This rapid review and guideline was developed by gastroenterologists and guideline methodologists from the 2 AGA committees.
T48 2492-2661 Sentence denotes The guideline panel worked collaboratively with the AGA Governing Board to develop the clinical questions, review the evidence profiles, and develop the recommendations.
T49 2662-2756 Sentence denotes Panel members disclosed all potential conflicts of interest according to AGA Institute policy.
T50 2758-2773 Sentence denotes Target Audience
T51 2774-2915 Sentence denotes The target audience of this guideline includes gastroenterologists, advanced practice providers, nurses, and other health care professionals.
T52 2916-2984 Sentence denotes Patients as well as policy-makers can benefit from these guidelines.
T53 2985-3111 Sentence denotes These guidelines are not intended to impose a standard of care for individual institutions, health care systems, or countries.
T54 3112-3258 Sentence denotes They provide the basis for rational informed decisions for clinicians, patients, and other health care professionals in the setting of a pandemic.